GF
JAZZ icon

Gerstein Fisher’s Jazz Pharmaceuticals JAZZ Stock Holding History

Gerstein Fisher’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,875
Closed -$780K – 415
2015
Q3 		$780K Hold
5,875
– – 0.12% 157
2015
Q2 		$1.03M Hold
5,875
– – 0.17% 135
2015
Q1 		$1.01M Hold
5,875
– – 0.17% 135
2014
Q4 		$960K Hold
5,875
– – 0.16% 133
2014
Q3 		$943K Sell
5,875
-4,772
-45% -$734K 0.17% 122
2014
Q2 		$1.56M Hold
10,647
– – 0.3% 62
2014
Q1 		$1.48M Buy
10,647
+2,255
+27% +$339K 0.3% 62
2013
Q4 		$5.84M Buy
+8,392
New +$868K 0.22% 116

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Gerstein Fisher's JAZZ Position: Q4 2015 in Review

Gerstein Fisher sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 5,875 shares — an estimated $780K sold.

Gerstein Fisher first reported a position in JAZZ in Q4 2013 and held it in 8 quarters. The position peaked at $5.84M in Q4 2013. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

  • Gerstein Fisher reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Gerstein Fisher sold 5,875 Jazz Pharmaceuticals shares in Q4 2015, an estimated $780K.
  • Gerstein Fisher first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 8 quarters.
  • Gerstein Fisher's Jazz Pharmaceuticals position peaked at $5.84M in Q4 2013.
  • 345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Gerstein Fisher's 13F filing for Q4 2015, filed 11 Feb 2016.